Changes in Pharmacodynamic Parameters during Co-administration of 5-FU with Warfarin: A Retrospective Case Series

Effect of 5-fluorouracil on mRNA expression of drug metabolizing enzyme and transporter genes in human hepatoma cell lines

(2021) Hideo SHIOHIRA et al.   BIOMEDICAL RESEARCH-TOKYO

Conflicting alterations in hepatic expression of CYP3A and enzyme kinetics in rats exposed to 5-fluorouracil: relevance to pharmacokinetics of midazolam

(2019) Shuhei Fukuno et al.   XENOBIOTICA

Sex-Dependent Adverse Drug Reactions to 5-Fluorouracil in Colorectal Cancer

(2019) Hyesol Lim et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial

(2018) Christina L. Fanola et al.   Journal of the American Heart Association

Direct oral anti-coagulants compared with vitamin-K inhibitors and low-molecular-weight-heparin for the prevention of venous thromboembolism in patients with cancer: A meta-analysis study

(2017) Natale Daniele Brunetti et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Altered tolbutamide pharmacokinetics by a decrease in hepatic expression of CYP2C6/11 in rats pretreated with 5-fluorouracil

(2017) Shuhei Fukuno et al.   XENOBIOTICA

Impact of capecitabine and S-1 on anticoagulant activity of warfarin in patients with gastrointestinal cancer

(2016) Tsuyoshi Hata et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Involvement of microRNA-141-3p in 5-fluorouracil and oxaliplatin chemo-resistance in esophageal cancer cells via regulation of PTEN

(2016) Ying-ying Jin et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

The Effects of 5-Fluorouracil on the Proteome of Colon Cancer Cells

(2013) Consuelo Marin-Vicente et al.   JOURNAL OF PROTEOME RESEARCH

New Insights into the RNA-Based Mechanism of Action of the Anticancer Drug 5′-Fluorouracil in Eukaryotic Cells

(2013) Laura Mojardín et al.   PLoS One

Increased anticoagulant activity of warfarin used in combination with doxifluridine

(2010) Masaru Nakajima et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Hydroxywarfarin Metabolites Potently Inhibit CYP2C9 Metabolism ofS-Warfarin

(2010) Drew R. Jones et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Comparison of the 5-Fluorouracil–Warfarin and Capecitabine-Warfarin Drug Interactions

(2010) Sachin R Shah et al.   PHARMACOTHERAPY

Cytochrome P450 Turnover: Regulation of Synthesis and Degradation, Methods for Determining Rates, and Implications for the Prediction of Drug Interactions

(2008) Jiansong Yang et al.   CURRENT DRUG METABOLISM